Biogen (BIIB) option IV into Clinical Trials on Alzheimer's Congress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Biogen (BIIB) option IV into Clinical Trials on Alzheimer's Congress

Biogen (BIIB) Stock Falls on Alzheimer's Drug Trial Death Reports

November 28, 2022 10:05 AM EST

Biogen (NASDAQ: BIIB) shares dipped Monday after a report by Science.org stated that a woman participating in a trial of experimental Alzheimer's treatment lecanemab had recently died from a brain hemorrhage.

According to the report, some researchers linked the brain hemorrhage to the drug. It is said to be the second death thought to be associated with lecanemab,... More